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Endothelial Cell Cortactin Phosphorylation by Src
Contributes to Polymorphonuclear Leukocyte
Transmigration In Vitro
Lin Yang, Jennifer R. Kowalski, Xi Zhan, Sheila M. Thomas, Francis W. Luscinskas
Abstract—The underlying mechanisms that regulate leukocyte transendothelial migration through the vascular endothelium remain unclear. Cortactin is a substrate of Src tyrosine kinases and a regulator of cytoskeletal dynamics. Previous
studies demonstrated a role for Src phosphorylation of cortactin in clustering of E-selectin and intercellular cell adhesion
molecule-1 around adherent leukocytes. In the current study, we used an in vitro flow model to investigate the role of
Src-induced cortactin phosphorylation in endothelium during polymorphonuclear leukocyte (PMN) transmigration
through human umbilical vein endothelium (HUVEC) monolayers preactivated with tumor necrosis factor-␣. Inhibition
of Src in HUVEC using Src kinase inhibitors PP2 and SU6656 reduced PMN transmigration by 45⫾8% and 36⫾6%,
respectively. Live cell imaging of green fluorescent protein–tagged cortactin in HUVEC revealed redistribution of
cortactin in the region surrounding transmigrating PMN. Knockdown of cortactin in HUVEC by small interfering RNA
also impaired transmigration to a similar degree, and this phenotype was rescued by reexpression of wild-type cortactin.
Analysis of the location of initial arrest and locomotion of PMN adherent to HUVEC demonstrated that inhibition of
Src tyrosine kinases or pretreatment with cortactin small interfering RNA reduced PMN transmigration at endothelial
cell-to-cell junctions and not adhesion. Tyrosine phosphorylation of cortactin was important for transmigration, because
expression of a mutant, in which the tyrosine phosphorylation sites were mutated to phenylalanine (cortactin3F), failed
to rescue PMN transmigration. Moreover, expression of cortactin3F alone partially blocked PMN transmigration. These
data suggest a model whereby tyrosine phosphorylation of cortactin by Src family kinases regulates PMN transmigration
(Circ Res. 2006;98:394-402.)
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A

key component of the inflammatory response is leukocyte recruitment to sites of injury, immune response, or
infection. Leukocytes interact with the vascular endothelium
through sequential, overlapping steps including leukocyte
arrest, rolling, firm adhesion, and ultimately transendothelial
migration (TEM) through the vascular endothelium to underlying tissues.1
Leukocyte adhesion or crosslinking of the endothelial
adhesion molecules E-selectin, intercellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1,
or P-selectin triggers association of these molecules with the
endothelial cytoskeleton and transmits outside-in signals that
include increases in both intracellular Ca2⫹ concentration and
myosin contractility and activation of p38 kinase, pp60src (Src),
and Rho GTPase family.2,3 These signals lead to rapid
cytoskeletal reorganization.1–3 Previous studies have shown
that treatment of endothelium with cytoskeletal disrupting
agents or inhibitors of myosin light-chain kinase (MLCK)

blocks leukocyte transmigration,4 suggesting that cytoskeletal
reorganization is necessary for leukocyte TEM.
Cortactin is an F-actin binding protein and an important
substrate of Src tyrosine kinases.5 Cortactin contains an
N-terminal acidic domain that binds the Arp2/3 complex
and a central repeat domain consisting of 6.5 tandem
repeats of 37 amino acids that binds F-actin. The
C-terminal region contains a Src homology 3 domain
(SH3) that interacts with a variety of cellular proteins. A
proline-rich region (PRR) between the tandem repeats and
SH3 domain contains tyrosine, serine, and threonine residues that are targets of phosphorylation.6 Tyrosine residues 421, 466, and 482 (within PRR) of murine cortactin
are important targets of Src tyrosine kinases. Expression of
a cortactin mutant with these tyrosine residues mutated to
phenylalanine impaired endothelial cell migration.7 Thus,
tyrosine phosphorylation of cortactin is important for its
role in cytoskeletal regulation.
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Recent studies reported that Src and cortactin associate
with ICAM-1 and E-selectin, providing connections between
these adhesion molecules and the cytoskeleton.8 Crosslinking
of E-selectin or ICAM-1 on endothelial cells or adhesion of
leukocytes (THP-1) to endothelial cells triggered Srcdependent tyrosine phosphorylation of cortactin. Inhibition of
Src by PP2 did not prevent association of E-selectin and
ICAM-1 with cortactin but did reduce THP-1 adhesion.9
However, the effect of PP2 on leukocyte TEM was not
addressed. Hence, the role of cortactin in leukocyte recruitment is of interest because it associates with ICAM-1 and
E-selectin, and its tyrosine phosphorylation by Src correlates
with adhesion of THP-1 cells. Recently we have found that
leukocyte function–associated antigen-1 on PMN rapidly
redistributes to form ring-like structures during PMN transmigration and colocalizes with its endothelial ligand ICAM1.10 Further studies by our laboratory showed that the
ICAM-1 cytoplasmic tail is required for TEM of PMN,11 in
line with previous reports that T cells have a similar requirement.12 Based on these observations, we hypothesized that
leukocyte adhesion triggers Src phosphorylation of cortactin,
which subsequently enables cortactin to integrate ICAM-1
engagement and cytoskeletal remodeling. Such a mechanism
might stabilize ICAM-1 clustering around adherent leukocytes and/or facilitate loosening of endothelial cell– cell
junctions during leukocyte transmigration. Herein, our results
indicate that Src-mediated tyrosine phosphorylation of cortactin in endothelial cells plays a significant role in PMN
transmigration.

Materials and Methods
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bled control, UAAGCUGAUAGUACUGGAGTT. A second cortactin
siRNA oligonucleotide (GGAGAGGAACUUGAAACATT; Ambion)
was also used. HUVEC were transfected with 50 nmol/L of siRNA
using Oligofectamine (Invitrogen, Carlsbad, Calif). After 3 days, PMN
transmigration studies were performed.

Retroviral Cortactin Production and Infection
Retrovirus production and infection were performed as previously
described.15 HUVEC were exposed to 2 rounds of retroviral infection, 6 and 3 days before being assayed in transmigration experiments. The expression level of green fluorescent protein (GFP)tagged cortactin relative to endogenous cortactin was determined by
Western blot. The level of cortactin was normalized to FAK to
correct for sample loading. The infection efficiency of the retroviral
constructs in HUVEC was variable (20% to 50%) as assessed by
fluorescence microscopy. For TEM studies, we addressed this
variability in infection efficiency by selecting microscope fields with
relatively high percentages of GFP-positive cells (GFP: 63⫾10%;
GFP-cortactin: 60⫾7%; cortactin3F-GFP: 59⫾6%; n⫽3 independent experiments, 30 fields for each cell type) that had similar levels
of GFP fluorescence per field as shown in Figure 6B.
The following constructs were used for expression of murine
cortactin in HUVEC cells: pBabe-GFP,15 pBabe-GFP-cortactin,15
MGIN-cortactin-GFP,7 and MGIN-cortactin3F-GFP (tyrosine 421,
466, and 482 residues mutated to phenylalanine7).

PMN Adhesion and Transmigration Assay
The live cell fluorescence microscopy flow model has been described.10,11 Confluent HUVEC monolayers were activated with
TNF-␣ (25 ng/mL, 4 hour) and inserted into the flow chamber.
Where indicated, HUVEC were preincubated with Alexa-568 tagged
anti–VE-cadherin mAb (10 minutes, 0.7 g/mL) to identify cell– cell
junctions.11 PMN (1⫻106/mL) suspended in flow buffer (DPBS
containing 0.1% human serum albumin, 0.75 mmol/L Ca2⫹ and
Mg2⫹) were drawn across HUVEC at 1.0 dyne/cm2 for 3 minutes,
followed by flow buffer alone for 10 minutes.

Image Acquisition and Analysis

Materials
Human recombinant tumor necrosis factor (TNF)-␣ was purchased
from Genzyme (Cambridge, Mass). PP2 and SU6656 were from
Calbiochem (San Diego, Calif). Hec-1 (a kind gift from Dr William
Muller, Weill Medical College, Cornell University, NY) is a nonblocking monoclonal antibody (mAb) to human VE-cadherin. Hec-1
was conjugated to Alexa 568 (Molecular Probes, Eugene, Ore) for
identification of endothelial cell– cell junctions.11 mAb to ICAM-1
(HU5/3), E-selectin (H18/7), VCAM-1 (E1/6), and nonbinding
control mAb K16/16 were used in fluorescence-activated cell sorter
(FACS) studies.13 For Western blotting, mAb to cortactin (4F11) was
purchased from Upstate Biotechnologies (Lake Placid, NY).

Endothelial Cell Culture and Leukocyte Isolation
Human umbilical vein endothelial cells (HUVEC) were isolated,
pooled, and cultured in M199 (BioWhittaker Bioproduct, Walkersville, Md) containing 10% FBS as previously described.14 Human
PMNs (⬎95% pure) were isolated from whole blood drawn from
healthy volunteers, anticoagulated with sodium citrate.11 The isolated PMNs were kept at 8°C and used in studies immediately and for
no more than 3 hours after isolation. Blood was drawn and handled
according to protocols for protection of human subjects approved by
the Brigham and Women’s Hospital Institutional Review Board, and
all volunteer subjects gave informed consent.

Cortactin Small Interfering RNA and Transfection
A predesigned small interfering RNA (siRNA) oligonucleotide targeting
human cortactin mRNA and a scrambled version of this sequence were
purchased from Ambion Inc (Austin, Tex). BLAST searches were
performed on both oligonucleotides to ensure the absence of nonspecific
targets. The sequences of the oligonucleotides are: cortactin siRNA
oligonucleotide (sense), GGGAGAAUGUCUUUCAAGATT; scram-

Live cell imaging of leukocyte TEM was performed using a digital
imaging system coupled to a Nikon TE2000 inverted microscope
equipped for differential interference contrast (DIC) microscopy as
detailed previously.11 For TEM experiments, sequential images of
VE-cadherin (red) or GFP-cortactin (green) and DIC were taken
every 15 sec for 10 minutes (unless noted otherwise) in a representative field, and at the end of flow, 4 additional fields were recorded
(each field/30 seconds). The number of accumulated leukocytes was
determined by counting the total number of adhered and transmigrated cells per field. The %TEM⫽total transmigrated leukocytes/
[total adhered⫹transmigrated leukocytes]⫻100. The location of
adherent PMN was calculated as the distance from the center of the
PMN to the nearest junction as identified by VE-cadherin staining.
Distances less than 5 m from the PMN to the junction were
considered as “junctional adhesion.”

Results
Inhibition of Src Family Kinase Activity in
Endothelium Impairs PMN Transmigration
Previous studies9 have shown that cortactin is tyrosine phosphorylated in response to ICAM-1 crosslinking, which was
abrogated by PP2, a Src family kinase–specific inhibitor.16
Similar results were seen in the current HUVEC system
(Figure I in the online data supplement available at http://
circres.ahajournals.org). Because ICAM-1 and its downstream signaling capabilities are important for leukocyte
TEM, we examined whether Src family kinases are required
for leukocyte TEM. Here, we used PP2 to inhibit Src family
kinases in HUVEC and determined whether PMN transmi-
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Figure 1. Inhibition of Src tyrosine kinase activity in HUVEC by
PP2 impairs PMN transmigration. HUVEC monolayers stimulated with 4 hours TNF-␣ were incubated with 10 mol/L PP2,
0.5% DMSO carrier, or medium alone for 30 minutes. Endothelial junctions were stained by Alexa 568 – conjugated VE-cadherin
mAb (Hec-1) as previously described11 to identify the location of
PMN arrest. PMN were drawn across HUVEC at 0.5 mL/min
(estimated shear stress, 1 dyne/cm2). The percentage of PMN
transmigration (A) and PMN accumulation (at 12 minutes) (B)
were determined by live cell imaging. C, The junctional and nonjunctional locations of adherent PMN on the endothelial monolayers at various time points were measured by overlapping
images of DIC and corresponding fluorescent images of
VE-cadherin staining as detailed in Materials and Methods. Data
shown represent the ratio of adherent PMN located at junctions
to the total accumulated PMN. *P⬍0.05 vs 0.5% DMSO at the
same time point. Data are mean⫾SEM; n⫽3 independent
experiments.

gration was affected. Robust PMN transmigration through
HUVEC monolayers treated with media or 0.5% dimethyl
sulfoxide (DMSO) (carrier) was observed, and the percentage
of PMN that transmigrated reached a plateau by 9 minutes
(Figure 1A). These data are consistent with our previous
observations.11 Pretreatment of HUVEC with PP2 reduced
PMN transmigration by 45⫾8% (mean⫾SD, P⬍0.05) as
compared with control carrier (Figure 1A). One possible
explanation for the reduction in TEM is that PP2 treatment
reduced PMN adhesion. Although a previous report observed
that PP2 reduced adhesion of THP-1 cells under static

conditions,9 no such effect was seen on PMN adhesion under
the defined laminar shear stress in these studies (Figure 1B).
The lack of effect on adhesion here could be explained by the
differences in leukocyte types studied and the adhesion
assays used. As a control experiment, treatment with PP2
neither reduced surface expression of adhesion molecules
(ICAM-1, E-selectin, or VCAM-1) nor disrupted VEcadherin staining at HUVEC cell– cell junctions (data not
shown). It is also unlikely that PP2 carryover affected PMN
functions, because HUVEC were washed extensively before
introducing PMN into the assay. Additionally, a study of PP2
effect on TEM of PMN was performed using flow buffer
containing 10% autologous plasma to mimic the in vivo
environment. Essentially the same level of inhibition on TEM
by PP2 was observed (52⫾9%).
We next used live cell imaging microscopy and the in vitro
flow model to evaluate whether PP2 altered the migratory
behavior of PMN adherent to HUVEC. We10,11 and others17
have shown that 70% to 80% of PMN initially attach close to
endothelial junctions and subsequently transmigrate at cell
junctions. To identify HUVEC cell– cell junctions, HUVEC
were stained with a nonblocking fluorescent-tagged VEcadherin mAb as described previously.11 This mAb neither
alter HUVEC permeability, nor the rate or extent of leukocyte
TEM.18 In HUVEC pretreated with carrier, most PMN
initially attached at endothelial junctions and subsequently
transmigrated through junctions and beneath the endothelial
monolayer. This process led to a reduction in PMN adhesion
at cell junctions over time (Figure 1C). In contrast, PP2
treatment of HUVEC reduced transmigration and significantly more PMN remained adherent at junctions, indicating
an effect on the transmigration step, rather than on adhesion.
Similar results for adhesion and TEM were obtained using a
second Src family kinase inhibitor, SU665619 (supplemental
Figure II). Taken together, these data argue that Src family
kinase activity is required for PMN transmigration.

Endothelial Cortactin Redistributes to the Site of
PMN Transmigration
As indicated above, cortactin is a substrate of Src family
kinases, and tyrosine phosphorylation of cortactin is detected
on engagement of adhesion molecules involved in TEM of
PMN.9 We hypothesized, therefore, that cortactin participates
in the regulation of PMN transmigration. To test this hypothesis, we first examined the distribution of cortactin in
HUVEC during PMN transmigration using live cell imaging
of GFP-tagged murine cortactin. Murine and human cortactin
are highly homologous, and murine GFP-cortactin has been
demonstrated to be functional in human cells.7 HUVEC
monolayers activated with TNF-␣ supported robust PMN
adhesion and transmigration at junctions in the in vitro flow
system, consistent with our previous observations.11 Analysis
of GFP-cortactin distribution in images obtained from 3
independent experiments showed that a small cluster of
GFP-cortactin appeared at the contact region between the
adherent PMN and endothelium. The GFP-cortactin became
more localized to PMN actively migrating at endothelial
cell-to-cell junctions and was often retained at endothelial
cell borders until well after PMN had completed transmigra-
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Figure 2. Endothelial cortactin redistributes to the site of PMN
transmigration. Real-time and live cell microscopy of GFPcortactin during PMN transmigrating through 4-hour TNF-␣–activated HUVEC monolayers expressing murine GFP-cortactin
under flow conditions, as described in Materials and Methods.
GFP-cortactin distribution (first column, green), corresponding
DIC images (second column, gray) and overlay of fluorescence,
and DIC (third column; DIC channel has been pseudocolored in
blue and overlaid to ensure clear separation from green) are
shown from PMN adhesion (time⫽0) to completion of transmigration (2:45 minutes). Arrows indicate clusters of GFPcortactin. Time is shown in minute:second. Bar, 10 m. The figure represents a typical sequence of events during PMN
transmigration from 3 independent experiments using HUVEC
and PMNs from multiple donors.

tion (Figure 2 and supplemental Video 1). Supplemental
Video 2 shows the distribution of GFP during PMN adhesion
and transmigration, as control. These data show that cortactin
is actively recruited to adherent PMN and accumulates at
HUVEC cell junctions during PMN transmigration.

Characterization of HUVEC Transfected With
Cortactin siRNA
To confirm the role of cortactin in the process of PMN
transmigration, we used cortactin siRNA to interfere with
cortactin expression in HUVEC. Transfection with cortactin
siRNA caused a 60% reduction in cortactin protein levels in
rest HUVEC (Figure 3A) or HUVEC activated with TNF-␣
for 4 hours (Figure 5A).
We next determined whether cortactin siRNA treatment
affected HUVEC junctions or expression of adhesion molecules induced by TNF-␣. Live cell epifluorescence micros-

Cortactin and Transendothelial Migration
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Figure 3. Characterization of HUVEC transfected with cortactin
siRNA. A, left, Western blot of cortactin in HUVEC transfected
with control or cortactin siRNA. FAK was used to control for
sample loading. Right, Cortactin protein levels on Western blots
were normalized to FAK protein. Data represent mean⫾SD; n⫽3
independent experiments. *P⬍0.05 vs control siRNA treatment.
B, Fluorescent micrographs of VE-cadherin staining of live, confluent HUVEC transfected with control or cortactin siRNA. Bar,
20 m. C, Surface expression of ICAM-1 on HUVEC without or
with 4 hours of TNF-␣ stimulation as assessed by indirect immunofluorescence staining and FACS. HUVEC were treated with
media, control siRNA, or cortactin siRNA.

copy using fluorescent-tagged VE-cadherin mAb showed no
obvious differences in the density or distribution pattern of
VE-cadherin between control (scrambled) and cortactin
siRNA-treated HUVEC (Figure 3B). FACS analysis demonstrated that transfection of cortactin siRNA did not alter
TNF-␣ induced surface expression of ICAM-1 (Figure 3C) or
E-selectin (data not shown).

Cortactin Is Required for PMN Transmigration
Through Endothelial Monolayers Activated
With TNF-␣
HUVEC monolayers transfected with control siRNA supported robust PMN transmigration (Figure 4A), similar to that
seen in HUVEC in the absence of siRNA (Figure 1A). In
contrast, cortactin siRNA pretreatment significantly reduced
PMN transmigration (Figure 4A). Impaired TEM was also
seen in HUVEC transfected with a second cortactin-specific
siRNA (see Materials and Methods; 47⫾9% inhibition,
P⬍0.05). Neither control nor cortactin siRNA altered PMN
accumulation (Figure 4B). Live cell microscopy revealed that
approximately 70% of PMN initially attached (time⫽0 min-
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GFP-cortactin expression. As shown in Figure 5A, Western
blot analysis showed that cortactin siRNA significantly reduced cortactin protein levels by ⬇60% (n⫽4, P⬍0.05).
Infection with the virus encoding GFP-tagged murine cortactin was able to increase cortactin levels in HUVEC monolayers treated with cortactin siRNA (Figure 5A). For TEM
studies, we selected microscope fields with a relatively high
percentage of GFP-positive cells (⬇60%). Whereas expression of GFP did not rescue defects in TEM in cortactin
siRNA-treated HUVEC, expression of GFP-cortactin did
rescue the TEM defect (Figure 5B). Interestingly, rescue of
TEM did not occur in fields with low numbers (⬍20%) of
GFP positive cells (data not shown). Accumulation of PMN
was not affected by any of these pretreatments (Figure 5C).
Taken together, these results demonstrate the specificity of
the cortactin siRNA approach combined with retroviral GFP
cortactin and a requirement for cortactin in efficient PMN
transmigration.

Src-Induced Phosphorylation of Cortactin Is
Important for PMN Transmigration

Figure 4. Transfection of HUVEC with cortactin siRNA impairs
PMN transmigration. HUVEC monolayers transfected with control or cortactin siRNA were stimulated with TNF-␣ (25 ng/mL, 4
hours). Endothelial junctions were stained by Alexa 568 – conjugated VE-cadherin mAb. The percentage of PMN transmigration
over time (A) and PMN accumulation (at 10 minutes) (B) were
determined as in the legend Figure 1. C, Locations of adherent
PMN at junctional or nonjunctional sites were determined as
described in Figure 1C. Data are mean⫾SEM; n⫽5 independent
experiments. *P⬍0.05 vs control siRNA at the same time point.

utes) at cell– cell junctions of HUVEC transfected with either
control or cortactin siRNA, and significantly more PMN
remained adherent at the junctions of cortactin siRNA-treated
HUVEC over time as compared with control siRNA (Figure
4C). In addition, we performed experiments with flow buffer
containing 10% plasma. A similar level of inhibition of TEM
by cortactin siRNA was observed (48⫾8%).
To further corroborate a specific role for cortactin in TEM,
studies were designed to reconstitute cortactin levels in
cortactin siRNA-transfected HUVEC using infection with
retrovirus encoding GFP-tagged murine cortactin.15 The design of cortactin siRNA was based on the sequence of the
human gene, whose sequence has mismatches with murine
cortactin. Thus, the cortactin siRNA does not affect murine

Previous studies have shown that tyrosine residues 421, 466,
and 482 in cortactin are important targets of Src kinase and
that overexpression of a cortactin mutant deficient in these
tyrosine residues in human endothelium led to impaired
endothelial cell migration.7 Given that Src family kinases are
required for TEM and that cortactin is regulated by Src family
kinases, we examined whether cortactin tyrosine phosphorylation was important for TEM.
Therefore, a GFP-tagged murine cortactin mutant
(cortactin3F-GFP7) in which tyrosine residues 421, 466, and
482 were substituted by phenylalanine was expressed in
HUVEC transfected with cortactin siRNA (Figure 6A). As
described in Materials and Methods, we selected microscope
fields that had maximal but similar levels of GFP expression
(Figure 6B). Consistent with the data in Figure 5, reconstitution with wild-type GFP-cortactin restored TEM to levels
seen in control siRNA HUVEC (Figure 6C). Interestingly,
expression of cortactin3F-GFP at the similar levels to that of
wide-type GFP-cortactin did not rescue PMN transmigration,
and, in fact, transmigration was consistently less than in
HUVEC transfected with cortactin siRNA alone (Figure 6C).
Infection of the mutant cortactin3F-GFP did not change the
accumulation of PMN on endothelial monolayers (data not
shown). Based on this result, we suspected that the
cortactin3F mutant would act as a dominant negative, blocking the function of endogenous cortactin. To test this hypothesis, HUVEC monolayers were infected with retrovirus
encoding GFP-tagged wild-type cortactin or cortactin3F, or
GFP as control. We selected microscope fields with relatively
high percentages of GFP-positive cells that had similar levels
of GFP fluorescence between wild-type and mutant cortactin.
Expression of wild type GFP-cortactin in HUVEC did not
alter TEM; however, similar levels of cortactin3F-GFP expression impaired PMN transmigration (29⫾6% inhibition;
Figure 6D) but had no effect on adhesion (data not shown).
Taken together, these data suggest that 1 mechanism by
which Src family kinases regulate TEM is through modulation of cortactin tyrosine phosphorylation.
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Figure 5. Reconstitution of cortactin siRNA-transfected HUVEC with murine GFP-cortactin rescues PMN transmigration. A, Expression
of endogenous cortactin and GFP-cortactin in HUVEC treated with siRNA and retrovirus (as indicated) was determined by Western blot
as described in Figure 3. Representative blot (top) and quantitation of cortactin levels (normalized to FAK) from 4 experiments (bottom)
are shown. Percentage of PMN transmigration through HUVEC monolayers (B) and accumulation of PMN (at 10 minutes) on HUVEC
treated with siRNA and retrovirus (as indicated) (C) were determined using live cell imaging. Values are mean⫾SEM of 3 independent
experiments. *P⬍0.05 vs control siRNA.

Discussion
In this study, we have identified a role for Src family kinases
and the cytoskeletal scaffold, cortactin, in regulation of TEM.
Our data argue that Src-dependent phosphorylation of cortactin is 1 mechanism by which Src family kinases regulate
leukocyte TEM. Using HUVEC activated with TNF-␣, which
have been previously reported to support robust PMN transmigration at cell– cell junctions under flow,11 we show here
that endothelial cortactin dynamically redistributes to cell–
cell junctions where PMN transmigrate. Pharmacological
inhibition of Src family kinases and siRNA knockdown of
endothelial cell cortactin reduced PMN transmigration at
cell– cell borders (paracellular TEM) without affecting PMN
initial attachment or localization to cell– cell junctions. We
further show that Src-induced cortactin phosphorylation at
tyrosine 421, 466, and 482 is critical for cortactin-mediated
PMN transmigration.
The live cell imaging of PMN transmigration revealed that
GFP-cortactin formed small, punctate clusters around PMN
before and during TEM and subsequently redistributed to the
leading edge of the endothelial membranes that resealed the
junctions once the PMN completed TEM (Figure 2 and
supplemental Videos 1 and 2). Recently, cortactin and Arp2/3
were shown to mediate endothelial cell cytoskeletal remodeling triggered by Sphingosine-1-phosphate through promot-

ing actin assembly at the cell leading edge.20 Hence, the
behavior of GFP-cortactin during TEM suggests that, in
addition to a role in localizing and stabilizing the association
of actin with adhesion molecules, cortactin, in association
with the Arp2/3 complex and cofactors, such as neural
Wiskott–Aldrich syndrome protein, promotes new actin polymerization and assembly into cortical actin at cell– cell
junctions. The newly formed actin filaments may provide a
source of rapid F-actin assembly at the cell junctions to reseal
the gap in VE-cadherin made by transmigrating PMN,18,21 as
well as give rise to actin rings, termed transmigration tunnels,
that surround leukocytes as they transmigrated in another
TEM assay system.22 The current finding that cortactin
clusters around adherent leukocytes is consistent with the
work of several groups showing that actin– cytoskeletal linker
proteins including cortactin, moesin, vinculin, ␣-actinin, and
vasodilator-stimulated phosphoprotein associate with endothelial cell adhesion molecules and cocluster with adherent
leukocytes.9,23–26 These associations regulate and stabilize the
location of adhesion molecules, and one could envision that
such regulation would be critical for the tracking of adherent
leukocytes as they position themselves to transmigrate. Future studies are necessary to evaluate the dynamics of
cortactin and actin in combination with junctional molecules
during transmigration and to delineate the mechanisms con-
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Figure 6. Tyrosine phosphorylation of cortactin is important for PMN transmigration. A, Expression of endogenous cortactin and murine
GFP-tagged wild-type or cortactin3F in the confluent HUVEC monolayer was determined by Western blot. B, Paired DIC and GFP fluorescence images of representative microscope fields of confluent HUVEC monolayers captured after 1 minute of PMN perfusion. Micrographs of GFP fluorescence demonstrate that wild-type GFP-cortactin (WT) and cortactin3F-GFP mutant (3F) have a similar percentage
of GFP-positive cells. The DIC images show attachment of PMN at the beginning of the flow. The average fluorescence intensity of
GFP-cortactin (WT) or cortactin3F-GFP mutant (3F) in the microscope fields used for TEM studies were quantitated using MetaMorph
software. Data represent mean⫾SD of 3 experiments (total 30 fields for each cell type). Bar, 20 m. C, HUVEC were transfected with
control or cortactin siRNA and then infected with murine GFP-tagged wild-type (WT) or cortactin3F-GFP mutant (3F) retroviruses, as
indicated. PMN transmigration was determined at 1 dyne/cm2 using time-lapse live cell imaging. *P⬍0.05 vs control siRNA. D, PMN
transmigration was determined in HUVEC expressing wild-type GFP-cortactin (WT) or cortactin3F-GFP mutant (3F) under flow. Data
represent mean⫾SEM of 3 independent experiments. *P⬍0.05 vs GFP control.

trolling the initiation and release of adhesion molecules from
actin binding proteins.
The PMN transmigration in this system is dependent on
ICAM-1.11 The association of cortactin with ICAM-1 and
subsequent tyrosine phosphorylation of cortactin by Src
tyrosine kinase in HUVEC is triggered by leukocyte adhesion
or crosslinking of ICAM-1.9 How cortactin associates with
ICAM-1 is unclear. The short cytoplasmic tail of ICAM-1 has
no obvious binding sites for cortactin. Thus the interaction
between cortactin and ICAM-1 could be indirectly through
other molecules like Src27 or SHP-2 (Src homology 2– con-

taining protein-tyrosine phosphatase-2).28 We speculate that
such associations bring Src and cortactin into close proximity,
at which point Src phosphorylates cortactin at tyrosine
residues. Future studies elucidating the precise nature of these
interactions may shed light on the signal relay between these
molecules during TEM.
Regardless of the nature of this association, our studies
clearly implicate a role for cortactin in regulation of TEM via
its tyrosine phosphorylation sites. Although cortactin tyrosine
phosphorylation has been shown to have both positive and
negative effects on cortactin function in various systems,29
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transmigration was clearly impaired by preventing tyrosine
phosphorylation of cortactin (Figure 1A) or by overexpression of cortactin3F in endothelial cells (Figure 6C). At least 2
potential models can be envisioned to explain how tyrosine
phosphorylation contributes to cortactin function in this
system. First, these sites may be important for recruiting
phosphotyrosine binding domain proteins. For example, these
sites have been shown to bind Src and the adaptor proteins
Crk.27,30 In the case of Src, it is possible that such an
interaction would potentiate activation of Src family kinases,
thus providing a positive feedback loop. Alternatively, phosphorylation of these residues may regulate other domains. For
example, Src-induced tyrosine phosphorylation of cortactin
decreases its F-actin cross-linking ability. Tyrosine phosphorylation of cortactin can also modulate its interaction with
MLCK,31,32 which binds to the cortactin SH3 domain. Interestingly, MLCK activity in HUVEC is required for TEM.4
Structure/function studies examining the role of other domains of cortactin in TEM may help to define how tyrosine
phosphorylation modulates TEM and further elucidate the
role of cortactin in TEM.
Cortactin can directly engage in actin assembly through
interaction with Arp2/3 complex and F-actin by its
N-terminal acidic domain (NAD) and tandem repeats, respectively.6 Given the modular nature of cortactin, however, it is
likely that other domains may also be required. For example,
recent studies have demonstrated that the C-terminal domain
of cortactin (including proline-rich region) and the
N-terminal domain can independently enhance cell motility.15
Thus, cortactin is likely to use multiple mechanisms to
regulate transmigration, and structure/function studies should
help elucidate the function of these other regions in TEM.
Our data provide strong evidence that Src and cortactin
contribute to PMN transmigration. However, the results do
not exclude involvement of other signaling pathways or
proteins in regulating PMN transmigration. Recently, studies
from other groups have shown that other cytoskeleton linker
proteins, such as ERM (ezrin and moesin) family members,
vinculin and ␣-actinin, colocalize with adhesion molecules
ICAM-1 and VCAM-1, and form endothelial “docking structures” around adherent or transmigrating leukocytes.24,26 These
structures may be important for strengthening the interaction of
adhesion molecules with their leukocyte ligands and facilitating
leukocyte TEM. Phosphoinositides and the Rho/p160 ROCK
pathway have been implicated in stabilizing endothelial cell
adhesion molecules during leukocyte adhesion or TEM.24 Future
studies are required to understand how Src and cortactin
integrate into the various signaling networks that regulate
leukocyte TEM.
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Supplemental Data:
Supplemental Fig.1. PP2 treatment abrogates cortactin tyrosine phosphorylation
triggered by ICAM-1 crosslinking. HUVEC were stimulated with TNF-α for 4h and
treated with 10µmol/L PP2 or 0.5% DMSO (carrier) for 30 min. ICAM-1 was crosslinked
by incubation of HUVEC with 10 µg/ml ICAM-1 mAb (HU5/3) for 30 min followed by
incubation with goat anti-mouse IgG (10µg/ml, 10min). Cortactin in cell lysates was
immunoprecipitated using cortactin mAb. A. The level of cortactin and tyrosine
phosphorylated cortactin were determined by western blot. B. The level of tyrosinephosphorylated cortactin was normalized to total cortactin levels.

Supplemental Fig.2. Inhibition of Src tyrosine kinases in HUVEC by SU6656
impairs PMN transmigration. TNF-α-activated endothelial monolayers were incubated
with 10µmol/L SU6656 or 0.5% DMSO (carrier), as indicated, for 30 min. Endothelial
junctions were stained by non-blocking Alexa 568-conjugated VE-cadherin mAb. A.
Percentage of PMN transmigration at various time points and B. PMN accumulation at 10
min was determined under flow using live cell imaging. C. The sites of adherent PMN at
junctional and non-junctional locations at various time points were measured by
overlapping images of DIC and corresponding fluorescent images of VE-cadherin
staining. Data are mean±SD of 3 independent experiments. * p<0.05, vs 0.5%DMSO at
the same time point.

Supplemental Video 1 and 2: Endothelial cortactin redistribution during PMN
transmigration. Supplement to Figure 2. HUVEC monolayers infected with retrovirus
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encoding murine GFP-cortactin (Video 1) or GFP (Video 2, control) were stimulated
with TNF-α for 4 hours. PMNs were drawn across the monolayer at 1 dyne/cm2.
Adhesion and TEM were monitored as described in Materials and methods. GFPcortactin (green) forms clusters around a transmigrating PMN (Video 1), while no cluster
was observed for GFP (Video 2). Bar, 10 µm. Time = min:sec (t = 0: initial adhesion of
PMN).
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